FDA NDC Directory · JSON-LD · Markdown

Renflexis

NDC 78206-162 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameinfliximab
Labeler / ManufacturerOrganon LLC
Marketing categoryBiologic License Application · App BLA761054
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsINFLIXIMAB (100 mg/1)
Marketing started20170421
Package count1

External sources

Source: openFDA. Public-domain (CC0).